■除了我们的人口越来越老,寿命越来越长,患认知障碍的风险增加。在初级保健的常规访视期间进行标准化筛查可能是早期发现轻度认知障碍(MCI)和随访认知变化的理想选择。
■此质量改进(QI)项目旨在确定实施Mini-Cog®快速筛查对早期痴呆症检测的影响,以识别和跟踪老年人在初级保健诊所环境中的认知障碍。
■实施于2024年2月在南加州的一家初级保健诊所开始。该项目总共收集了16周的数据。该QI项目使用Mini-Cog©实施了常规认知筛查。发现了认知障碍,如果Mini-Cog©分数表明,我们启动了认知评估和护理计划服务的随访.数据来自项目现场的电子病历,总样本量为471名参与者(实施前小组n=382,实施后小组n=89)。
■Pearson卡方检验表明,认知障碍的识别率有统计学上的显着改善,从实施前的11.8%(382个中的45个)增加到实施后的34.8%(89个中的31个),特别是,轻度认知障碍从实施前的零增加到实施后的12.4%(n=11/89).最后,实施后的随访率从91.1%(45个中的41个)提高到100%(31个中的31个),根据PHI系数(φ=0.196),临床意义很明显,表明效应大小小,随访率100%。
■该项目的结果表明,老年人应接受认知筛查,以帮助识别早期认知障碍并增加随访以进行进一步评估。治疗,和先进的护理计划。
UNASSIGNED: Beyond our population growing older and living longer, there is an increased risk of developing a cognitive disorder. Standardized screening during a routine visit in primary care may be ideal for early detection of mild cognitive impairment (MCI) and follow-up for cognitive changes.
UNASSIGNED: This quality improvement (QI) project aimed to determine the impact of implementing the Mini-Cog© quick screening for early dementia detection to identify and follow up on the cognitive impairment of older adults in a primary care clinic setting.
UNASSIGNED: Implementation started in February 2024 in a primary care clinic in Southern California. Data was collected for this project over a total of 16 weeks. This QI project implemented a routine cognitive screening using the Mini-Cog©. Cognitive impairment was identified, and if indicated by the Mini-Cog© scores, follow-up for a cognitive assessment and care plan services were initiated. Data were obtained from the project site\'s electronic medical record on a total sample size of 471 participants (n = 382 in the pre-implementation group and n = 89 in the post-implementation group).
UNASSIGNED: Pearson\'s chi-square test indicated a statistically significant improvement in the identification rate of cognitive impairment, increasing from 11.8% (n = 45 out of 382) at pre-implementation to 34.8% (n = 31 out of 89) at post-implementation, and specifically, mild cognitive impairment increased from zero identified in pre-implementation to 12.4% (n = 11 out of 89) post-implementation. Lastly, follow-up rates improved from 91.1% (n = 41 out of 45) to 100% (n = 31 out of 31) in post-implementation, and clinical significance was evident based on the phi-coefficient (φ = 0.196), indicating a small effect size and a 100% follow-up rate.
UNASSIGNED: The findings of this project suggest older adults should receive cognitive screenings to help identify early cognitive impairment and increase follow-up for further evaluation, treatment, and advanced care planning.